Attending the BiotechX USA conference in Philadelphia? It’s the premier conference for R&D teams who understand the impact of digital transformation across the entire precision medicine value chain.
Stop by booth #603 to chat with QuartzBio’s Precision Medicine AI Agents. We’ll demonstrate how our AI agents act as secure, personalized virtual assistants, delivering Sample and Biomarker Intelligence Solutions for translational research, informatics, sample/biomarker operations, and IT teams.
These agents help you with everyday tasks such as finding data, answering questions, surfacing analytics, and prescriptive recommendations for risk-mitigating actions.
See how you can unlock 10X faster access to insights and a >2X boost in team productivity, accelerating study close and time-to-market.
https://www.quartz.bio/wp-content/uploads/2025/08/QB_LInkedIn_BioTechX2025_1200x1200_Blue.jpg12001200Chandreyee Dashttps://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svgChandreyee Das2025-09-15 13:45:282025-09-15 13:46:29Join QuartzBio at BiotechX 2025: Explore Precision Medicine AI Agents
This month, we released version 12.0.0 of QuartzBio’s Precision Medicine AI Agent Platform, featuring enhancements to our Sample Intelligence Solution, our Biomarker Intelligence Solution, and improvements to the underlying data management layer.
If you’re a current customer, please reach out to your QuartzBio Project Manager to learn more about accessing these features!
Highlights of What’s New:
Larger file sizes (uploads can be up to 200 Gb or more) improve support for large data sets and multimodal insights.
Dynamic sample analytics: Flexible new Sample Intelligence data tables and dashboards, including new data quality dashboards (Figure 1), provide a user-friendly alternative to static HTML reports.
More accurate sample forecasting: Project visits beyond study end dates.
Richer insights: Detailed clinical response data available in Biomarker Intelligence data tables. You can now publish clinical response data types “status” and “grade” to your analysis-ready data asset (Figure 2).
Figure 1. Examples of new sample data quality dashboard options: Gain insights into discrepancies in sample data across multiple systems (Central Lab, Testing Lab, EDC) to support data quality and integrity in clinical studies.
Figure 2. Clinical response “Grade” and “Status” are now options for adding to your Biomarker Intelligence data tables. These values can then be used for analysis via swimmer and waterfall plots, for rich clinical insights.
What’s coming next in QuartzBio’s product roadmap? Contact us to join our upcoming Innovation Summits (October-November 2025) — we’ll be gathering input from sponsor teams and sharing previews of new features.
https://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svg00Chandreyee Dashttps://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svgChandreyee Das2025-08-29 15:17:392025-08-29 15:17:40QuartzBio Platform Version 12.0.0: Large File Support, Dynamic Analytics, Richer Clinical Insights
On Demand
Duration: 30 minutes
Sign up to watch the webinar on demand:
What you’ll learn:
Your team is tasked with data storytelling.
Every day, you’re pressed to turn complex biomarker, clinical, and sample datasets into actionable insights. To stay competitive, your team needs to report findings in minutes, not hours or weeks.
Unlock the speed you need with QuartzBio’s Precision Medicine AI Agents, which power our Biomarker and Sample Intelligence solutions by serving as secure, personalized assistants for stakeholders across the entire precision medicine value chain. They deliver 10x faster* insights within a unified, self-serve platform, amplifying the impact of every team member.
Join Bill Hall as he chats with these AI Agents, showing how generative AI saves time and powers collaboration across multiple teams:
Faster Operations: e.g., 10X faster identification of consented samples with mutation data, split by treatment arm
Faster Informatics & Data Management: e.g., automatic data ingestion, QC, and mapping; application of FAIR principles, access control, and automated workflows
Faster Translational Research: e.g., in minutes, perform statistical analyses of assay data, incorporating clinical metadata and contextual information
You’ll learn how QuartzBio’s approach transforms the way precision medicine teams work with 360° intelligence.
Who should attend:
Translational Scientists
Biomarker Operations and Biospecimen Operations Teams
**QuartzBio internal study, comparing Agent Intelligence to traditional workflows and point solutions, as determined via time-motion analysis.
https://www.quartz.bio/wp-content/uploads/2025/08/QB_LinkedIn_Webinar-SEPT2025_1200x1200_-VOD_Orange.jpg12001200QuartzBio Teamhttps://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svgQuartzBio Team2025-08-08 13:27:532025-09-15 13:10:48Webinar — AI Agents in Action: 10X Faster Insights Across the Precision Medicine Ecosystem
Time-saving global filters: Instead of applying the same filters across multiple charts in a dashboard, you can now apply dashboard-level common filters, and all visualizations will instantly reflect your filtered dataset.
Improve collaboration and onboarding with organizational sharing: New “share with all” functionality enables organization-level permissions. New users can access dashboards as soon as they log in.
Visualization engine enhancements:
Statistical tests, including parametric and nonparametric tests, for richer biomarker data analysis / visualization (Figure 1)
Sample testing status heatmap for rapid insights (Figure 2)
Figure 1. Statistical tests are now available, including statistical tests for boxplots: Compare boxplots within a series to determine if their mean difference is statistically significant.
Figure 2. Sample status heatmaps added as visualization options. Gain rapid insights into multiple sample statuses to track sample collection or testing, as part of our Sample Intelligence Solution.
by Tobi Guennel, PhD, SVP of Product Innovation, QuartzBio
I just read Microsoft’s latest Work Trend Index report, “The Year the Frontier Firm Is Born,” and it resonates deeply with the challenges and opportunities we’re seeing in precision medicine R&D.
The report highlights a seismic shift: the rise of AI agents isn’t just about automating tasks; it’s about fundamentally rewiring how businesses operate.
Key takeaways from the report include:
Intelligence on Tap: AI is becoming an abundant, on-demand resource, offering “digital labor” to bridge the gap between increasing business demands and human capacity.
Human-Agent Teams: The future isn’t human vs. machine, but human + machine. Teams will increasingly integrate AI agents as “digital colleagues,” shifting the focus from functional silos to outcome-driven “Work Charts”. This requires a new mindset, viewing AI not just as a tool, but a thought partner.
Every Employee an Agent Boss: Managing and directing AI agents will become a core skill across all levels, accelerating careers and enabling more strategic work earlier.
This vision of AI-augmented work mirrors the complexities we navigate daily in the precision medicine value chain.
Currently, getting answers often involves a complex “information ping-pong” across various teams and systems, delaying critical insights. Clinical trials generate vast amounts of data, yet extracting timely value remains a significant hurdle for many organizations.
At QuartzBio, we believe the future lies in connecting this intricate value chain. We envision a future empowered by a seamless, semi-autonomous system – our Precision Medicine AI Agent Platform. This network of specialized AI agents is designed not to replace human expertise, but to amplify it.
Our platform aims to:
Autonomously ingest and manage complex data streams across the R&D ecosystem.
Enable conversational interaction, allowing researchers and operational teams to interrogate data and receive insights in seconds, not weeks.
Proactively deliver rich, contextual information to support strategic decision-making.
Foster interoperability and collaboration, breaking down data silos.
By integrating human ingenuity with intelligent agents, we can shift the focus from manual processes to strategic insight generation, ultimately accelerating the delivery of novel treatments.
The “Frontier Firm” concept isn’t just a future hypothetical; it’s the operational model we are building towards in life sciences today.
https://www.quartz.bio/wp-content/uploads/2025/04/QB_LinkedIn_AI-Agents-Reshape_1200x1200_A.jpg12001200Chandreyee Dashttps://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svgChandreyee Das2025-04-29 12:32:272025-05-09 15:45:29The Dawn of the Frontier Firm: How AI Agents Are Reshaping Work & Precision Medicine
Duration: 30 minutes, on demand
Sign up to watch the webinar:
What you’ll learn:
R&D teams in biomarker-rich clinical trials are constantly chasing insights around a complex data ecosystem. By the time stakeholders find their data, gain access, ideate on the right analysis and get results, the chance to make impactful decisions may be over.
Domain-specific AI agents, orchestrated by our Precision Medicine Virtual Assistant, enable operations, translational, and informatics teams to conversationally interact with a connected ecosystem of biomarker, sample, and clinical data.
Join Bill Hall as he chats with the Virtual Assistant, conversationally extracting insights in seconds, achieving:
Amplified Operational Efficiency: e.g., “Show me biopsy samples from patients in the 70th percentile of JAK2 expression at baseline”
Autonomous Workflows & Interoperability: e.g., automatically ingesting and harmonizing assay data upon arrival from testing lab
Amplified Translational Research: e.g., ““Compare gene expression profiles for responders vs non-responders at baseline”
You’ll learn how QuartzBio’s approach transforms the way precision medicine teams work with 360° intelligence.
Who should attend:
Translational Scientists
Biomarker Operations and Biospecimen Operations Teams
https://www.quartz.bio/wp-content/uploads/2025/04/LinkedIn_MAY-Webinar_1200x1200_Grey-A-2.jpg12001200Chandreyee Dashttps://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svgChandreyee Das2025-04-11 13:34:422025-05-22 12:39:13Webinar: Precision Medicine AI Agents Accelerate Data-to-Insights
Watch the full episode:
Tobi Guennel, PhD, SVP of Product Innovation at QuartzBio, joins AI expert Srivatsan Nagaraja to discuss his insights on integrating AI into the precision medicine value chain in an episode of the Life Sciences D’n’A Podcast.
Tune in to learn about:
Leveraging AI and advanced analytics to improve clinical trial efficiency
Using AI agents to automate clinical trial operations
https://www.quartz.bio/wp-content/uploads/2025/03/QB_LinkedIn_Integration-AI-Podcast_1200x1200.jpg12001200Chandreyee Dashttps://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svgChandreyee Das2025-03-27 19:07:382025-07-07 14:16:49Podcast: Integrating AI into Precision Medicine
19 December 2024 — Before we celebrate the new year, let’s celebrate new feature releases, brought to you by the winning collaboration between QuartzBio’s product teams, managed services teams, and, most of all, our clients.
This month, we released version 10.0.0 of QuartzBio’s Precision Medicine AI Agent Platform, delivering enhancements to the enterprise Biomarker Data Management (eBDM) and virtual Sample Inventory Management (vSIM) use cases for biomarker and sample intelligence, as well as the underlying Enterprise Data Platform, which supports data management activities.
If you’re a current QuartzBio user, log in now to see how these features and improvements can help you work faster and impress your colleagues.
Highlights of What’s New
Sample Intelligence (vSIM) and Biomarker Intelligence (eBDM) products:
Create tailored plots easily and update plots in real time with more flexible visualization tools (Figure 1)
Easily navigate, filter, sort Data Hub and Dashboard elements with intuitive new layouts
Group connected resources of different types with new “Activity” tag (Figure 2)
Faster access to vSIM reports with more customizable data table outputs
Figure 1. New plot options enhance readability, offering full labels, color palette selection, and more flexible plot rendering.
Figure 2. Activity Tag: Quickly identify all resources related to a specified “Activity” (e.g., Sample Collection Monitoring) using this new tag and filter.
Enterprise Data Platform (EDP data management layer):
Improved efficiency and accuracy with enhanced file and vault management
Robust process tracking with auditable trail of user actions
Slice data faster with enhanced Global Search queries (Figure 3)
Figure 3. Advanced global search filters: Efficiently perform advanced global searches by applying filters directly from the UI. R and Python queries are automatically generated based on the filter values, saving time and eliminating manual steps.
Feedback?
We love to hear from current and potential users! Let us know your thoughts on this release and ideas for future enhancements!
https://www.quartz.bio/wp-content/uploads/2024/12/Figure-1-for-24R3-post-1.png664829Chandreyee Dashttps://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svgChandreyee Das2024-12-19 10:10:362025-04-08 17:41:36QuartzBio Platform Version 10.0.0: Flexibility, Efficiency and Accuracy
Interoperability in Precision Medicine: What does it mean?
In modern drug development, connectedness is crucial for success, especially in remote and decentralized teams. This connectedness involves linking people and information to extract shared insights from data and make faster decisions.
In practice, this means ensuring interoperability of data, technology, systems, and ecosystems through a scalable, modular data fabric architecture. It connects various data sources, including enterprise data lakes, biomarker data, sample data, clinical sites, real-world information, and public databases, to create a robust data and insights supply chain (Figure 1, below).
Interoperability in Precision Medicine: Why does it matter?
Interoperability is vital for precision medicine as it enables seamless integration of applications and workflows for data analysis, storage, and processing. This reduces human intervention, minimizes variability, and enhances data reproducibility.
The Data-Value Gap: Only 32% of companies have reported being able to extract business value from their data, and only 27% have described the output of data and analytics projects as being “highly actionable.” Interoperability of systems and technologies closes this gap.
QuartzBio’s Precision Medicine AI Agent Platform uses a fully interoperable, scalable, and modular data fabric solution to maintain connectivity with all data streams across complex technology and vendor ecosystems generated by R&D programs. This platform supports cross-ecosystem interoperability and generates insights using business intelligence tools.
QuartzBio’s approach drives value for multiple teams by unifying point solutions and enabling sample and biomarker insights to flow freely between operations teams, translational researchers, data science/bioinformatics teams, and business executives, thus powering decision-making for day-to-day use cases.
By creating a data fabric architecture to ingest and harmonize data and technologies spanning across this complex ecosystem, QuartzBio’s Precision Medicine AI Agent Platform can serve as either a standalone enterprise system supporting Precision Medicine, or a robust system that can integrate seamlessly and serve domain-specific functions in the context of the broader drug ecosystem.
/
QuartzBio’s approach drives value for multiple teams by unifying point solutions and enabling sample and biomarker insights to flow freely between operations teams, translational researchers, data science/bioinformatics teams, and business executives, thus powering decision-making for day-to-day use cases.
By creating a data fabric architecture to ingest and harmonize data and technologies spanning across this complex ecosystem, QuartzBio’s Precision Medicine AI Agent Platform can serve as either a standalone enterprise system supporting Precision Medicine, or a robust system that can integrate seamlessly and serve domain-specific functions in the context of the broader drug ecosystem.
The Opportunity: Closing the Data-Value Gap
As sponsors invest more and more resources in generating data as part of clinical programs, there is increasing pressure to close the data-value gap. Because QuartzBio’s platform is built to be fully interoperable with clients’ systems and applications, clients can recognize immediate value across multiple functions across their enterprise.
Figure 1. A typical Precision Medicine Ecosystem and how QuartzBio’s Precision Medicine AI Agent Platform fits within it, providing data fabric architecture tailored for Precision Medicine.
https://www.quartz.bio/wp-content/uploads/2024/11/QuartzBio-approach-to-interoperability_.jpg11171080Chandreyee Dashttps://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svgChandreyee Das2024-11-21 14:18:572025-03-26 10:35:52System and Ecosystem Interoperability: How Connectedness Drives Drug Development
Ask a question, get an answer, and gain valuable insights across the precision medicine data ecosystem.
Powered by the first network of Precision Medicine AI Agents.
Supercharges the day-to-day work of translational researchers, data scientists, and informatics teams.
Join Bill Hall as he chats with QuartzBio’s Virtual Assistant, conversationally extracting insights in seconds with questions such as:
“Which mutations have highest prevalence at baseline?”
“Which subjects are in the 70th percentile of JAK2 expression at baseline and have stored, consented, baseline samples?”
“What is the correlation of JAK2 and STAT1 expression at baseline across samples?”
You’ll discover QuartzBio’s approach, which employs smart, automated integration of biomarker, sample, and clinical data to create a unified data ecosystem – now amplified with the power of conversational interactions to enable more consumable insights, regardless of your data expertise.
Who should attend:
Translational Scientists Data Science and Bioinformatics Teams R&D Information Technology (IT)
https://www.quartz.bio/wp-content/uploads/2024/07/Linkedin_Webinar-SEPT2024_Empowering-PM-with-Conversational-AI_On-Demand_Update.jpg12001200QuartzBio Teamhttps://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svgQuartzBio Team2024-07-26 19:14:102025-07-25 17:11:08Webinar: Empowering Precision Medicine with Conversational AI — A New Era of Biomarker Intelligence
